TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,546,298 | +13.2% | 143,292 | +15.1% | 0.00% | – |
| Q2 2023 | $2,249,824 | +679.6% | 124,506 | +442.3% | 0.00% | – |
| Q1 2023 | $288,595 | +26.6% | 22,959 | +47.7% | 0.00% | – |
| Q4 2022 | $227,875 | +14.5% | 15,544 | +33.8% | 0.00% | – |
| Q3 2022 | $199,000 | -45.3% | 11,620 | -53.4% | 0.00% | – |
| Q2 2022 | $364,000 | +233.9% | 24,946 | +283.8% | 0.00% | – |
| Q1 2022 | $109,000 | -54.6% | 6,499 | -39.0% | 0.00% | – |
| Q4 2021 | $240,000 | +92.0% | 10,662 | +84.8% | 0.00% | – |
| Q3 2021 | $125,000 | +119.3% | 5,771 | +194.4% | 0.00% | – |
| Q2 2021 | $57,000 | -80.9% | 1,960 | -78.8% | 0.00% | – |
| Q1 2021 | $298,000 | +388.5% | 9,237 | +522.9% | 0.00% | – |
| Q4 2020 | $61,000 | – | 1,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |